Glenn Dranoff
Impact in
- Immunology top 0.02%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 154
- Immunotherapy and Immune Responses 117
- Immune Cell Function and Interaction 65
- T-cell and B-cell Immunology 34
- Oncology 101
- Cancer Immunotherapy and Biomarkers 54
- CAR-T cell therapy research 49
- Co-authors
- Ira Mellman (1 shared paper)George Coukos (1 shared paper)Matthew W. Vanneman (9 shared papers)Michael Dougan (11 shared papers)Richard C. Mulligan (19 shared papers)F. Stephen Hodi (28 shared papers)David Mooney (10 shared papers)Martín C. Mihm (23 shared papers)
- Journals
- Blood (19 papers)Cancer Immunology Research (14 papers)Proceedings of the National Academy of Sciences (12 papers)Cancer Research (9 papers)Clinical Cancer Research (9 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Glenn Dranoff
196 papers receiving 26.3k citations
Glenn Dranoff's Hit Papers
Peers
Comparison fields: 5 of 155
- Immunology 15.3k
- Oncology 11.6k
- Genetics 1.2k
- Cancer Research 1.5k
- Molecular Biology 6.6k
Countries citing papers authored by Glenn Dranoff
This map shows the geographic impact of Glenn Dranoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Dranoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Dranoff more than expected).
Fields of papers citing papers by Glenn Dranoff
This network shows the impact of papers produced by Glenn Dranoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Dranoff. The network helps show where Glenn Dranoff may publish in the future.
Co-authors
The 25 scholars most cited alongside Glenn Dranoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer immunotherapy comes of age Hit paper breakdown → | 2011 | 3210 |
| 2 | Combining immunotherapy and targeted therapies in cancer treatment Hit paper breakdown → | 2012 | 1281 |
| 3 | Cytokines in cancer pathogenesis and cancer therapy Hit paper breakdown → | 2004 | 1229 |
| 4 | Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Hit paper breakdown → | 2003 | 829 |
| 5 | Prospects for combining targeted and conventional cancer therapy with immunotherapy Hit paper breakdown → | 2017 | 789 |
| 6 | Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules Hit paper breakdown → | 1997 | 750 |
| 7 | Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis Hit paper breakdown → | 1994 | 744 |
| 8 | Coinhibitory Pathways in Immunotherapy for Cancer Hit paper breakdown → | 2016 | 695 |
| 9 | TIM-1 and TIM-4 Glycoproteins Bind Phosphatidylserine and Mediate Uptake of Apoptotic Cells Hit paper breakdown → | 2007 | 541 |
| 10 | Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients Hit paper breakdown → | 2008 | 514 |
| 11 | Immune Therapy for Cancer Hit paper breakdown → | 2008 | 511 |
| 12 | 2006 | 488 | |
| 13 | 1998 | 481 | |
| 14 | 2014 | 473 | |
| 15 | 1999 | 459 | |
| 16 | 2010 | 396 | |
| 17 | 2009 | 384 | |
| 18 | 2015 | 374 | |
| 19 | 2013 | 365 | |
| 20 | Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. | 2000 | 354 |
About Glenn Dranoff
Glenn Dranoff is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Hematology, having authored 198 papers that have together received 26.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (117 papers), Immune Cell Function and Interaction (65 papers), Cancer Immunotherapy and Biomarkers (54 papers), CAR-T cell therapy research (49 papers), T-cell and B-cell Immunology (34 papers), Virus-based gene therapy research (18 papers), RNA Interference and Gene Delivery (16 papers) and Cancer Research and Treatments (13 papers). The work is most often cited by research in Immunology (15.3k citations), Oncology (11.6k citations), Genetics (1.2k citations), Cancer Research (1.5k citations) and Molecular Biology (6.6k citations). Glenn Dranoff has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Ira Mellman, George Coukos, Matthew W. Vanneman, Michael Dougan, Richard C. Mulligan, F. Stephen Hodi, David Mooney, Martín C. Mihm, Gordon J. Freeman and Arlene H. Sharpe. Their work appears in journals such as Blood, Cancer Immunology Research, Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.